CD95 Signaling in Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|17|2809-2818

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2809-2818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2834-2842

Bentham Science Publishers

Access to resources Recommend Favorite

C-KIT Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2849-2880

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-beta Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2934-2947

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2899-2911

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 841-863

Bentham Science Publishers

Access to resources Recommend Favorite